LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for Deka Biosciences, Inc and Millions of Other Companies

Sign up for full access to Deka Biosciences, Inc information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Cutting-Edge Biotechnology Deka Biosciences, Inc. is at the forefront of biotechnology research, focusing on innovative targeted cytokine therapies for cancer and inflammatory diseases. This cutting-edge approach presents a unique opportunity for partnership in pioneering treatments.

Growing Financial Potential Despite being an early-stage company with revenue in the $0-10M range, Deka has secured $30M in funding. This signals investor confidence and suggests potential growth opportunities for collaborative ventures or investments.

Niche Technology Expertise With a tech stack that includes WordPress, Google Cloud, and more, Deka Biosciences showcases a specialized technological foundation. Leveraging their expertise in these areas could open up avenues for tech-driven partnerships.

Targeted Market Differentiation Deka's DiakineTM platform offers tailored solutions by combining disease-specific cytokines. This targeted approach presents a compelling proposition for market differentiation and potential collaboration with companies seeking personalized treatment options.

Strategic Employee Advantage With a compact team of 11-50 employees, Deka Biosciences maintains agility and focus. This suggests a strategic advantage in swift decision-making and personalized client interactions that could appeal to partners seeking flexible and responsive collaborations.

Similar companies to Deka Biosciences, Inc

✕

Access Insights for Deka Biosciences, Inc and Millions of Other Companies

Sign up for full access to Deka Biosciences, Inc information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Deka Biosciences, Inc Tech Stack

Deka Biosciences, Inc uses 8 technology products and services including WordPress, Google Cloud, Stimulus, and more. Explore Deka Biosciences, Inc's tech stack below.

  • WordPress
    Content Management System
  • Google Cloud
    Infrastructure As A Service
  • Stimulus
    Javascript Frameworks
  • Flickity
    Javascript Libraries
  • Lightbox
    Javascript Libraries
  • Elementor
    Page Builders
  • PHP
    Programming Languages
  • Apache HTTP Server
    Web Servers

Media & News

Deka Biosciences, Inc's Email Address Formats

Deka Biosciences, Inc uses at least 1 format(s):
Deka Biosciences, Inc Email FormatsExamplePercentage
LastF@dekabiosciences.comDoeJ@dekabiosciences.com
50%
LastF@dekabiosciences.comDoeJ@dekabiosciences.com
50%

Frequently Asked Questions

Where is Deka Biosciences, Inc's headquarters located?

Minus sign iconPlus sign iconDeka Biosciences, Inc's main headquarters is located at 20271 Goldenrod Lane Suite 2087 Germantown, MD 20876 US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Deka Biosciences, Inc's official website and social media links?

Minus sign iconPlus sign iconDeka Biosciences, Inc's official website is dekabiosciences.com and has social profiles on LinkedIn.

How much revenue does Deka Biosciences, Inc generate?

Minus sign iconPlus sign icon As of October 2024, Deka Biosciences, Inc's annual revenue reached $3.8M.

What is Deka Biosciences, Inc's SIC code NAICS code?

Minus sign iconPlus sign iconDeka Biosciences, Inc's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Deka Biosciences, Inc have currently?

Minus sign iconPlus sign iconAs of October 2024, Deka Biosciences, Inc has approximately 43 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer And Co-Founder: J. M.Chief Executive Officer: J. M.Chief Financial Officer: K. D.. Explore Deka Biosciences, Inc's employee directory with LeadIQ.

What industry does Deka Biosciences, Inc belong to?

Minus sign iconPlus sign iconDeka Biosciences, Inc operates in the Biotechnology Research industry.

What technology does Deka Biosciences, Inc use?

Minus sign iconPlus sign iconDeka Biosciences, Inc's tech stack includes WordPressGoogle CloudStimulusFlickityLightboxElementorPHPApache HTTP Server.

What is Deka Biosciences, Inc's email format?

Minus sign iconPlus sign iconDeka Biosciences, Inc's email format typically follows the pattern of . Find more Deka Biosciences, Inc email formats with LeadIQ.

How much funding has Deka Biosciences, Inc raised to date?

Minus sign iconPlus sign icon As of October 2024, Deka Biosciences, Inc has raised $30M in funding. The last funding round occurred on Dec 08, 2023 for $30M.
Deka Biosciences, Inc

Deka Biosciences, Inc

Biotechnology ResearchMaryland, United States11-50 Employees

Deka Biosciences, Inc., is an early-stage biotechnology company focused on generating the next generation targeted cytokine therapies to treat cancer and inflammatory diseases.  Deka is developing the dual cytokine, (DiakineTM) platform. Diakines are comprised of optimized, stimulatory, or suppressive disease specific IL-10 variants coupled to other stimulatory or suppressive cytokines via a T1/2 life extending tissue targeting, non-immunogenic scFv technology.

✕

Access Insights for Deka Biosciences, Inc and Millions of Other Companies

Sign up for full access to Deka Biosciences, Inc information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
20271 Goldenrod Lane Suite 2087 Germantown, MD 20876 US
Website
dekabiosciences.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $30M

    Deka Biosciences, Inc has raised a total of $30M of funding over 4 rounds. Their latest funding round was raised on Dec 08, 2023 in the amount of $30M.

  • $10M

    Deka Biosciences, Inc's revenue is in the range of $10M

Section iconFunding & Financials

  • $30M

    Deka Biosciences, Inc has raised a total of $30M of funding over 4 rounds. Their latest funding round was raised on Dec 08, 2023 in the amount of $30M.

  • $10M

    Deka Biosciences, Inc's revenue is in the range of $10M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for Deka Biosciences, Inc and Millions of Other Companies

Sign up for full access to Deka Biosciences, Inc information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.